Company page

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. is a public company traded under the ticker DYN in the American market. With a market capitalization of approximately $3 billion, Dyne focuses on developing innovative therapies for patients with serious diseases. The company is dedicated to advancing its proprietary technology platform to address unmet medical needs.